Form 4: Moderna's Chief Legal Officer Reports Stock Transactions
SEC Form 4 Filing
Chief Legal Officer Shannon Thyme Klinger reports the acquisition and disposal of Moderna (MRNA) stock, including transactions related to restricted stock units and tax obligations.
Summary
- On March 1, 2024, Shannon Thyme Klinger, Moderna's Chief Legal Officer, acquired 233 shares of common stock through the vesting of restricted stock units (RSUs).
- Also on March 1, 2024, 233 shares were disposed of.
- On March 4, 2024, Klinger disposed of 117 shares at a price of $94.3383 per share to cover tax withholding obligations related to the vesting of RSUs.
- Following these transactions, Klinger directly owns 8,673 shares of Moderna common stock and 1,861 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an insider, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for corporate insiders to report their transactions in company stock, providing transparency to investors.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency of insider trading activities.
- Similar filings are made by executives at companies like Pfizer (PFE) and BioNTech (BNTX) when they trade their company's stock.
- The 'sell to cover' transaction for tax obligations is a common practice across many companies with equity compensation plans.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are routine and related to executive compensation and tax obligations.
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 03/01/2023 | 25% of the shares subject to the restricted stock unit award vested. |
| 03/01/2024 | Acquisition of 233 shares through RSU vesting and disposal of 233 shares. |
| 03/04/2024 | Sale of 117 shares at $94.3383 to cover tax obligations. |
| 03/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.